fda glp 1 green list The US has established a “green list” of imported GLP-1 drug ingredients deemed safe and allowed into the country, while keeping out those from unverified foreign sources. The agency had identified FDA Proposes to Exclude GLP-1s

The synergy with growth hormone signaling may explain why some users report enhanced results when combining BPC-157 with growth hormone secretagogues or other regenerative compounds

Here, we review the pharmacokinetics, pharmacokinetic drugdrug interactions (DDIs), and pharmacokinetic modeling approaches of four currently available GLP-1 RAs (exenatide, liraglutide, dulaglutide, and semaglutide) and tirzepatide

Systemic therapy is first-line for any tinea beyond a single small lesion: oral itraconazole 200 mg daily for 68 weeks (or longer until clinical and mycological cure) is now preferred over terbinafine 250 mg in regions with documented resistance, with baseline and 4-weekly liver function and lipid profile monitoring

Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET